Cargando…
Autoimmune phenotypes in schizophrenia reveal novel treatment targets
Typical and atypical antipsychotics are the first-line treatments for schizophrenia, but these classes of drugs are not universally effective, and they can have serious side effects that impact compliance. Antipsychotic drugs generally target the dopamine pathways with some variation. As research of...
Autores principales: | Severance, Emily G., Dickerson, Faith B., Yolken, Robert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097895/ https://www.ncbi.nlm.nih.gov/pubmed/29742478 http://dx.doi.org/10.1016/j.pharmthera.2018.05.005 |
Ejemplares similares
-
Complex Gastrointestinal and Endocrine Sources of Inflammation in Schizophrenia
por: Severance, Emily G., et al.
Publicado: (2020) -
Role of Immune and Autoimmune Dysfunction in Schizophrenia
por: Severance, Emily G., et al.
Publicado: (2016) -
High throughput sequencing for the identification of novel infectious agents associated with human psychiatric disorders
por: Yolken, Robert, et al.
Publicado: (2012) -
From Infection to the Microbiome: An Evolving Role of Microbes in Schizophrenia
por: Severance, Emily G., et al.
Publicado: (2019) -
THE MICROBIOME-THE MISSING LINK IN THE PATHOGENESIS OF SCHIZOPHRENIA
por: Yolken, Robert, et al.
Publicado: (2014)